Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab-Reference-Cited by-同舟云学术

Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab

Published:2017-11-27 Issue:2 Volume:7 Page:e1395125
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Hardy-Werbin M.¹²,Arpí O.¹,Taus A.³,Rocha P.³,Joseph-Pietras D.⁴,Nolan L.⁵,Danson S.⁶,Griffiths R.⁷,Lopez-Botet M.⁸,Rovira A.¹,Albanell J.¹³,Ottensmeier C. H.⁹⁴,Arriola E.¹³

Affiliation:

1. Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

2. Universitat de Barcelona, Barcelona, Spain

3. Medical Oncology Department, Hospital del Mar-CIBERONC, Barcelona, Spain

4. NIHR Experimental Cancer Medicine Centre, Southampton, United Kingdom

5. Medical Oncology Department, University Hospital Southampton, Southampton, United Kingdom

6. Sheffield Experimental Cancer Medicine Centre, Weston Park Hospital, Sheffield, United Kingdom

7. Medical Oncology Department, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom

8. Immunology unit, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain

9. Cancer Science Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1395125

Reference63 articles.

1. Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results

2. Small cell lung cancer: Where do we go from here?

3. Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

4. Treatment options for small cell lung cancer – do we have more choice?

5. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in predictive biomarkers associated with immunotherapy in extensive-stage small cell lung cancer;Cell & Bioscience;2024-09-12

2. Small Cell Lung Cancer Neuronal Features and Their Implications for Tumor Progression, Metastasis, and Therapy;Molecular Cancer Research;2024-06-24

3. Initial screening for neuronal autoantibodies and their putative impact on survival in patients with small‐cell lung cancer;Thoracic Cancer;2024-05-04

4. The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events;Rheumatic Disease Clinics of North America;2024-05

5. Anti-SOX-1 Antibody-Positive Paraneoplastic Limbic Encephalitis Diagnosed During Small Cell Lung Cancer Treatment;Cureus;2023-07-31